Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Working Capital Changes: 2013-2024

Historic Other Working Capital Changes for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to -$93.6 million.

  • Wave Life Sciences' Other Working Capital Changes fell 68.84% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.2 million, marking a year-over-year decrease of 400.11%. This contributed to the annual value of -$93.6 million for FY2024, which is 272.27% down from last year.
  • Per Wave Life Sciences' latest filing, its Other Working Capital Changes stood at -$93.6 million for FY2024, which was down 272.27% from $54.3 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Other Working Capital Changes registered a high of $54.3 million during FY2023, and its lowest value of -$93.6 million during FY2024.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$4.3 million (2022), whereas its average is -$14.5 million.
  • In the last 5 years, Wave Life Sciences' Other Working Capital Changes surged by 1,361.10% in 2023 and then tumbled by 272.27% in 2024.
  • Yearly analysis of 5 years shows Wave Life Sciences' Other Working Capital Changes stood at -$20.1 million in 2020, then rose by 8.03% to -$18.5 million in 2021, then skyrocketed by 76.67% to -$4.3 million in 2022, then surged by 1,361.10% to $54.3 million in 2023, then plummeted by 272.27% to -$93.6 million in 2024.